Company News in the Life Science Industry

»

Reset 

Real Time Medical Systems Appoints Steven M. Stein, MD as Chief Medical Officer

BALTIMORE, Sept. 17, 2020 /PRNewswire/ -- Real Time Medical Systems (Real Time), the leading post-acute interventional analytics... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2020
Related companies:  Real Time Primers, LLC

Amytrx Therapeutics Emerges from Stealth to Develop Novel Therapies for Inflammatory Diseases with Lead Program AMTX-100 Currently in Clinical Development for Dermatologic Indications

NASHVILLE, Tenn., Sept. 17, 2020 /PRNewswire/ -- Amytrx Therapeutics, Inc., ("Amytrx"), a clinical stage biopharmaceutical company advancing next-generation inflammation-targeting therapies, today launched from stealth to announce the company's novel therapeutic platform, clinical development... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2020

NRL, NCATS Scientists Develop Method to Safely Study COVID-19, Other Contagious Diseases

WASHINGTON, Sept. 17, 2020 /PRNewswire/ -- Scientists and researchers at the U.S. Naval Research Laboratory and National Center for Advancing Translational Sciences (NCATS) submitted their findings to ACS Nano, a monthly peer-reviewed scientific journal, on their collaboration to develop SARS-CoV-2... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2020
Related companies:  Advancing Synergy, LLC | National Center for Advancing Translational Sciences (NCATS) | Advancing Drugs

The Playbook guides the safe and effective use of digital clinical measures across clinical research, patient care and public health

BOSTON, Sept. 17, 2020 /PRNewswire/ -- Today, multidisciplinary stakeholders invite partners across clinical, technology, nonprofit, and academic research to shape the industry-wide essential guide for developing and deploying digital clinical measures to advance patient care, clinical research,... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2020

Menarini Ricerche Announces Dose Escalation Results of the Clinical Trial of MEN1611 in Breast Cancer

POMEZIA, Italy, Sept. 17, 2020 /CNW/ -- Menarini Ricerche, the R&D division of the Menarini Group, today announced the results of the dose escalation part of its B-PRECISE-01 clinical trial (NCT03767335) which is evaluating MEN1611, a potent and selective phosphatidylinositol 3-kinase (PI3K)... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2020

MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer

PLANEGG/MUNICH, Germany and SHANGHAI, China, Sept. 17, 2020 /PRNewswire/ -- MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) and I-Mab (Nasdaq: IMAB) today jointly announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2020

MobileHelp® Named Top Workplace in South Florida

BOCA RATON, Fla., Sept. 17, 2020 /PRNewswire/ -- MobileHelp®, a leader in mobile Personal Emergency Response Systems (mPERS) and healthcare... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2020

Home Care Assistance Hosts Inaugural World Alzheimer's Day Virtual Convention

SAN FRANCISCO, Sept. 17, 2020 /PRNewswire/ -- Home Care Assistance, the largest private-pay provider of in-home... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2020

World Outlook for Industrial Enzymes 2020 - Industrial Enzymes in Household Care Forecast to Grow at 9% Y-o-Y Due to Surge in Sales Driven by COVID-19 Related Events

DUBLIN, Sept. 17, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 17 Sep 2020

Protagonist Therapeutics to Participate in the Jefferies Next Generation IBD Therapeutics Virtual Summit 2020

NEWARK, Calif., Sept. 17, 2020 /PRNewswire/ -- Protagonist Therapeutics, Inc. (NASDAQ:PTGX) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the upcoming Jefferies Next Generation IBD Therapeutics Virtual Summit 2020.

Read more ››
By: PR Newswire Association LLC. - 17 Sep 2020
Related companies:  Protagonist Therapeutics Inc.

Global Anti-Asthmatics and COPD Drugs Market Forecast to Reach $83.8 billion by 2023

DUBLIN, Sept. 17, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 17 Sep 2020

Precision Optics Corporation Schedules Fourth Quarter and Fiscal Year 2020 Conference Call for Thursday, September 24, 2020

GARDNER, Mass., Sept. 17, 2020 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") today announced that it has scheduled a conference call to discuss fourth quarter and fiscal year 2020 financial results on Thursday, September 24, 2020 at 5:00pm ET.

Read more ››
By: PR Newswire Association LLC. - 17 Sep 2020
Related companies:  Precision Optics Corporation, Inc.

American Diabetes Association® Empowers Youth at Home Nationwide through Project Power

ARLINGTON, Va., Sept. 17, 2020 /PRNewswire/ -- Keeping our young people healthy and active amid coronavirus related closures is essential, and while organizations continue to scramble and pivot, the American Diabetes Association(®) (ADA) has transformed Project Power virtually. Project Power... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2020
Related companies:  American Diabetes Association

The Woolroom Launches Sleep Environment Bundles in the US

DENVER, Sept. 17, 2020 /PRNewswire/ -- The Woolroom, the world's premium wool bedding manufacturer, launches in the US this week, with online ordering and customized bundles available now for American consumers.

Read more ››
By: PR Newswire Association LLC. - 17 Sep 2020

ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020

HOUSTON and VANCOUVER, BC, Sept. 17, 2020 /PRNewswire/ - ESSA Pharma Inc. (Nasdaq: EPIX) (TSX-V: EPI), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced the presentation of data of ESSA's clinical candidate, EPI-7386,... Read more ››

By: PR Newswire Association LLC. - 17 Sep 2020
Related companies:  ESSA Pharma Inc.

Checkpoint Therapeutics Announces Positive Interim Results from Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Checkpoint Therapeutics, Inc. | Checkpoint Surgical | ImmunoBrain Checkpoint, Inc

Chi-Med Announces Second NDA Acceptance in China for Surufatinib in Pancreatic Neuroendocrine Tumors

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Hutchison China MediTech Limited (Chi-Med)

Global WholeHealth Partners Corp. (GWHP) Announces It Had Submitted an Emergency Use Authorization (EUA) Application # PEUA201789 Date 09/14/2020: for the Global Antigen CoViD19 SARS2 Rapid Test as Mentioned in the 8K Filing on 09/15/20

Read more ››
By: GlobenewsWire - 17 Sep 2020

Ventura Cannabis (VCAN) and Vibe Bioscience (VIBE) Close Cathedral Sale

Read more ››
By: GlobenewsWire - 17 Sep 2020

Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological and Solid Tumors

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Precision BioSciences Inc.
«  1  2  3  4  5  6  7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies